Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | L01XC09 |
UNII: | M2HPV837HO |
Primary Target | |
---|---|
CD3e |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Neoplasms | 4 | D009369 | ClinicalTrials |
Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
Ascites | 2 | D001201 | ClinicalTrials |
Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 509077-98-9 |
ChEMBL | CHEMBL2108581 |
FDA SRS | M2HPV837HO |
Guide to Pharmacology | 7385 |